Phoenix atherectomy for patients with peripheral artery disease
Sorin Giusca1, Saskia Hagstotz1, Michael Lichtenberg2
1GRN Hospital Weinheim, Cardiology and Vascular Medicine, Weinheim, Germany.
The Phoenix atherectomy is a safe endovascular treatment for complex peripheral artery disease (PAD) lesions. It shows acceptable rates of target lesion revascularisation (TLR) and low bail-out stenting, improving outcomes for PAD patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Peripheral artery disease (PAD) affects millions globally, necessitating effective treatments for complex and calcified lesions.
- Endovascular atherectomy offers a minimally invasive approach to plaque removal in PAD.
- The Phoenix atherectomy system is a newer device for PAD treatment.
Purpose of the Study:
- To evaluate the safety and long-term effectiveness of the Phoenix atherectomy.
- To assess outcomes in patients with complex and calcified lesions in PAD.
- To analyze device-related complications and revascularization rates.
Main Methods:
- A consecutive series of all-comer PAD patients underwent Phoenix atherectomy.
- Device safety was assessed by monitoring perforations and distal embolizations.
- Lesion calcification (PACSS) and complexity (TASC) were categorized.
- Clinically driven target lesion revascularization (TLR) was the primary effectiveness endpoint.
Main Results:
- 558 lesions in 402 patients were treated, with a mean follow-up of 15.7 months.
- The majority of lesions were complex (TASC C/D, 82%) and calcified (PACSS ≥2, 80%).
- Low rates of perforation (1%) and asymptomatic embolization (2%) were observed.
- Freedom from TLR was 87.5% for claudication and 82.3% for critical limb-threatening ischemia (CLTI).
Conclusions:
- The Phoenix atherectomy is a safe endovascular option for complex PAD lesions.
- The device demonstrates a low rate of bail-out stenting.
- Clinically acceptable target lesion revascularization rates were achieved in PAD patients.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
